www.newsmax.com
Ozempic Reduces Cardiac Risks in Diabetes Patients
Novo Nordisk's widely used diabetes drug Ozempic delayed progression of chronic kidney disease in diabetes patients‚ a large late-stage study found‚ cutting the risk of major cardiac events and death by 24%. Around 40% of people with Type 2 diabetes have chronic kidney...